These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
4. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436 [TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates. Seifert H; Stefanik D; Wisplinghoff H J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293 [No Abstract] [Full Text] [Related]
6. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii. Ozbek B; Sentürk A Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399 [TBL] [Abstract][Full Text] [Related]
7. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates. Kiratisin P; Apisarnthanarak A; Kaewdaeng S Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913 [TBL] [Abstract][Full Text] [Related]
8. Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii. Kempf M; Djouhri-Bouktab L; Brunel JM; Raoult D; Rolain JM Int J Antimicrob Agents; 2012 Feb; 39(2):180-1. PubMed ID: 22100281 [No Abstract] [Full Text] [Related]
9. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients. Vourli S; Frantzeskaki F; Meletiadis J; Stournara L; Armaganidis A; Zerva L; Dimopoulos G Int J Antimicrob Agents; 2015 Jun; 45(6):670-1. PubMed ID: 25795317 [No Abstract] [Full Text] [Related]
10. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations. Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402 [TBL] [Abstract][Full Text] [Related]
12. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan. Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678 [TBL] [Abstract][Full Text] [Related]
13. Increasing frequency of class 1 and 2 integrons in multidrug-resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance. Ramírez MS; Stietz MS; Vilacoba E; Jeric P; Limansky AS; Catalano M; Centrón D Int J Antimicrob Agents; 2011 Feb; 37(2):175-7. PubMed ID: 21177078 [No Abstract] [Full Text] [Related]
14. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore. Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075 [TBL] [Abstract][Full Text] [Related]
15. Surveillance for multidrug-resistant Acinetobacter baumannii: a lesson on definitions. Ho PL; Ho AY; Chow KH; Cheng VC Int J Antimicrob Agents; 2010 Nov; 36(5):469-71. PubMed ID: 20727720 [No Abstract] [Full Text] [Related]
17. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Touati M; Diene SM; Racherache A; Dekhil M; Djahoudi A; Rolain JM Int J Antimicrob Agents; 2012 Jul; 40(1):89-91. PubMed ID: 22580030 [No Abstract] [Full Text] [Related]
18. Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. Barnaud G; Zihoune N; Ricard JD; Hippeaux MC; Eveillard M; Dreyfuss D; Branger C J Hosp Infect; 2010 Dec; 76(4):358-60. PubMed ID: 20692729 [No Abstract] [Full Text] [Related]
19. Emergence of an extreme-drug-resistant (XDR) Acinetobacter baumannii carrying blaOXA-23 in a patient with acute necrohaemorrhagic pancreatitis. Grosso F; Quinteira S; Peixe L J Hosp Infect; 2010 May; 75(1):82-3. PubMed ID: 20303617 [No Abstract] [Full Text] [Related]
20. Class 2 integrons in multidrug-resistant Acinetobacter baumannii circulating in different Brazilian geographic regions. Fonseca ÉL; Freitas Fdos S; Scheidegger ÉM; Jacinto T; Vicente AC Int J Antimicrob Agents; 2011 Jul; 38(1):95-6. PubMed ID: 21550785 [No Abstract] [Full Text] [Related] [Next] [New Search]